• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Aldosterone antagonists destabilize the mineralocorticosteroid receptor.醛固酮拮抗剂会使盐皮质激素受体不稳定。
Biochem J. 1992 Mar 15;282 ( Pt 3)(Pt 3):697-702. doi: 10.1042/bj2820697.
2
Differences between aldosterone and its antagonists in binding kinetics and ligand-induced hsp90 release from mineralocorticosteroid receptor.醛固酮与其拮抗剂在结合动力学以及配体诱导热休克蛋白90从盐皮质激素受体释放方面的差异。
J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):815-21. doi: 10.1016/0960-0760(92)90430-q.
3
Mineralocorticosteroid receptor of the chick intestine. Oligomeric structure and transformation.
J Biol Chem. 1989 Jun 5;264(16):9304-9.
4
Characterization of human mineralocorticosteroid receptor expressed in the baculovirus system.在杆状病毒系统中表达的人盐皮质激素受体的特性分析。
Proc Natl Acad Sci U S A. 1991 Dec 1;88(23):10681-5. doi: 10.1073/pnas.88.23.10681.
5
Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor.依普利酮、螺内酯和醛固酮与盐皮质激素受体结合的决定因素差异。
Clin Exp Pharmacol Physiol. 2004 Oct;31(10):704-9. doi: 10.1111/j.1440-1681.2004.04079.x.
6
Sulfhydryl groups are involved in the binding of agonists and antagonists to the human mineralocorticoid receptor.巯基参与激动剂和拮抗剂与人盐皮质激素受体的结合。
J Steroid Biochem Mol Biol. 1996 Mar;57(5-6):315-21. doi: 10.1016/0960-0760(95)00278-2.
7
Mineralocorticoid (type I) receptors in the olfactory mucosa of the mammal: studies with [3H]aldosterone and the anti-mineralocorticoid spironolactone.哺乳动物嗅黏膜中的盐皮质激素(I型)受体:用[3H]醛固酮和抗盐皮质激素螺内酯进行的研究
Chem Senses. 1997 Apr;22(2):141-8. doi: 10.1093/chemse/22.2.141.
8
Mechanism of action of the potent sodium-retaining steroid 11, 19-oxidoprogesterone.
Mol Pharmacol. 2000 Jul;58(1):58-70. doi: 10.1124/mol.58.1.58.
9
Histone deacetylase inhibition, but not a mineralocorticoid receptor antagonist spironolactone, attenuates atypical transcription by an activating mutant MR (MRS 810L ).组蛋白去乙酰化酶抑制作用可减弱激活型突变体盐皮质激素受体(MRS 810L)介导的非典型转录,但盐皮质激素受体拮抗剂螺内酯则无此作用。
Clin Exp Pharmacol Physiol. 2016 Oct;43(10):995-1003. doi: 10.1111/1440-1681.12614.
10
Putative steroid binding domain of the human mineralocorticoid receptor, expressed in E. coli in the presence of heat shock proteins shows typical native receptor characteristics.人盐皮质激素受体的假定类固醇结合结构域,在热休克蛋白存在的情况下于大肠杆菌中表达,显示出典型的天然受体特征。
J Steroid Biochem Mol Biol. 1996 Jan;57(1-2):43-50. doi: 10.1016/0960-0760(95)00250-2.

引用本文的文献

1
The infralimbic mineralocorticoid blockage prevents the stress-induced impairment of aversive memory extinction in rats.边缘下区皮质酮阻断可防止应激引起的大鼠厌恶记忆消退受损。
Transl Psychiatry. 2022 Aug 24;12(1):343. doi: 10.1038/s41398-022-02118-2.
2
Aldosterone antagonists in the treatment of hypertension and target organ damage.醛固酮拮抗剂在高血压及靶器官损害治疗中的应用
Curr Hypertens Rep. 2001 Jun;3(3):240-8. doi: 10.1007/s11906-001-0046-2.
3
Antagonism in the human mineralocorticoid receptor.人盐皮质激素受体中的拮抗作用。
EMBO J. 1998 Jun 15;17(12):3317-25. doi: 10.1093/emboj/17.12.3317.
4
Involvement of the N-terminal region of the human mineralocorticoid receptor hormone-binding domain in agonist and antagonist binding as revealed by a new monoclonal antibody.一种新型单克隆抗体揭示人盐皮质激素受体激素结合域N端区域参与激动剂和拮抗剂结合
Biochem J. 1997 May 15;324 ( Pt 1)(Pt 1):57-63. doi: 10.1042/bj3240057.
5
Ligand-induced conformational change in the human mineralocorticoid receptor occurs within its hetero-oligomeric structure.配体诱导的人盐皮质激素受体构象变化发生在其异源寡聚结构内。
Biochem J. 1996 Apr 15;315 ( Pt 2)(Pt 2):421-7. doi: 10.1042/bj3150421.
6
Characterization of the interaction of the human mineralocorticosteroid receptor with hormone response elements.人盐皮质激素受体与激素反应元件相互作用的表征
Biochem J. 1993 Jun 1;292 ( Pt 2)(Pt 2):577-83. doi: 10.1042/bj2920577.
7
Differential intracellular localization of human mineralocorticosteroid receptor on binding of agonists and antagonists.人盐皮质激素受体在激动剂和拮抗剂结合时的细胞内差异定位
Biochem J. 1994 Aug 15;302 ( Pt 1)(Pt 1):191-7. doi: 10.1042/bj3020191.
8
Corticosteroid receptor antagonists: a current perspective.皮质类固醇受体拮抗剂:当前视角
Pharm World Sci. 1995 Mar 24;17(2):31-41. doi: 10.1007/BF01875052.

本文引用的文献

1
Mechanism of the antimineralocorticoid effects of spirolactones.螺内酯抗盐皮质激素作用的机制。
Kidney Int. 1981 Jul;20(1):1-6. doi: 10.1038/ki.1981.97.
2
Effects of urea and molybdate on the chick oviduct progesterone receptor.尿素和钼酸盐对雏鸡输卵管孕酮受体的影响。
Biochem Biophys Res Commun. 1983 Jul 29;114(2):479-87. doi: 10.1016/0006-291x(83)90805-7.
3
RU 38486: potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activation.RU 38486:强效抗糖皮质激素活性,与对胞质糖皮质激素受体的强结合相关,随后是激活受损。
J Steroid Biochem. 1984 Jan;20(1):271-6. doi: 10.1016/0022-4731(84)90216-4.
4
Monoclonal antibody to chicken oviduct progesterone receptor.抗鸡输卵管孕酮受体单克隆抗体。
Proc Natl Acad Sci U S A. 1983 May;80(10):2854-8. doi: 10.1073/pnas.80.10.2854.
5
Characterization of spironolactone binding sites distinct from aldosterone receptors in rat kidney homogenates.大鼠肾匀浆中与醛固酮受体不同的螺内酯结合位点的特性研究
Biochem Pharmacol. 1984 Jul 15;33(14):2277-81. doi: 10.1016/0006-2952(84)90667-1.
6
Binding and antimineralocorticoid activities of spirolactones in toad bladder.蟾蜍膀胱中螺内酯的结合及抗盐皮质激素活性
Am J Physiol. 1983 Jan;244(1):C24-31. doi: 10.1152/ajpcell.1983.244.1.C24.
7
Common non-hormone binding component in non-transformed chick oviduct receptors of four steroid hormones.四种甾体激素的未转化鸡输卵管受体中的常见非激素结合成分。
Nature. 1984;308(5962):850-3. doi: 10.1038/308850a0.
8
Renal aldosterone receptors: studies with (3H)aldosterone and the anti-mineralocorticoid (3H)spirolactone (SC-26304).肾醛固酮受体:用(3H)醛固酮和抗盐皮质激素(3H)螺内酯(SC - 26304)进行的研究
Proc Natl Acad Sci U S A. 1974 Apr;71(4):1431-5. doi: 10.1073/pnas.71.4.1431.
9
Evidence that the 90-kDa phosphoprotein associated with the untransformed L-cell glucocorticoid receptor is a murine heat shock protein.
J Biol Chem. 1985 Oct 15;260(23):12398-401.
10
Antiglucocorticosteroid effects suggest why steroid hormone is required for receptors to bind DNA in vivo but not in vitro.抗糖皮质激素作用表明了为何甾体激素在体内而非体外是受体与DNA结合所必需的。
Nature. 1987;328(6131):624-6. doi: 10.1038/328624a0.

醛固酮拮抗剂会使盐皮质激素受体不稳定。

Aldosterone antagonists destabilize the mineralocorticosteroid receptor.

作者信息

Couette B, Lombes M, Baulieu E E, Rafestin-Oblin M E

机构信息

Lab. Hormones, INSERM U 33, Bicêtre, France.

出版信息

Biochem J. 1992 Mar 15;282 ( Pt 3)(Pt 3):697-702. doi: 10.1042/bj2820697.

DOI:10.1042/bj2820697
PMID:1313229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1130843/
Abstract

To elucidate the mechanism of action of aldosterone antagonists, we studied the interaction of spironolactone with the chick mineralocorticosteroid receptor (MR). Intestinal cytosol contains specific spironolactone-binding sites (Kd approximately 3 nM; max. no. of binding sites approximately 100 fmol/mg of protein) that have been identified as MRs by competition experiments with steroid ligands and with the monoclonal anti-idiotypic antibody H10E that interacts with aldosterone-binding domain of the MR. Binding studies indicate that aldosterone and spironolactone bind to the MR through a common site that encompasses the epitope recognized by H10E. At 4 degrees C, spironolactone dissociates much more rapidly from the cytosol 8-9 S form of MR (t1/2 38 min) than does aldosterone (t1/2 3240 min). A high dissociation rate was also observed for progesterone, a natural aldosterone antagonist (t1/2 84 min). The covalent linkage of the 90 kDa heat shock protein (hsp90) to the ligand-binding subunit of MR with dimethyl pimelimidate did not notably modify the rate of dissociation of spironolactone from the receptor (t1/2 96 min), excluding the possibility that the rapid dissociation rate of the antagonist was related to hsp90 release. The effects of aldosterone and the two anti-mineralocorticosteroids on the 8-9 S heterooligomeric structure of the MR differed strikingly. Using low-salt density-gradient centrifugation analysis, aldosterone-labelled receptors were recovered as 8-9S complexes, whereas 4 S entities were detected after spironolactone and progesterone binding. This indicated that, under the experimental conditions used, aldosterone antagonists facilitate hsp90 release and thus do not stabilize the non-DNA-binding 8-9S form of MR. We propose that the combination of rapid dissociation of the ligand and a weakened hsp90-receptor interaction is involved in the anti-mineralococorticosteroid activity of aldosterone antagonists.

摘要

为阐明醛固酮拮抗剂的作用机制,我们研究了螺内酯与鸡盐皮质激素受体(MR)的相互作用。肠细胞溶质含有特异性螺内酯结合位点(解离常数约为3 nM;最大结合位点数约为100 fmol/mg蛋白质),通过与类固醇配体以及与与MR醛固酮结合域相互作用的单克隆抗独特型抗体H10E进行竞争实验,这些位点已被鉴定为MR。结合研究表明,醛固酮和螺内酯通过一个共同位点与MR结合,该位点包含H10E识别的表位。在4℃时,螺内酯从MR的细胞溶质8 - 9S形式上解离的速度(半衰期38分钟)比醛固酮(半衰期3240分钟)快得多。对于天然醛固酮拮抗剂孕酮,也观察到了较高的解离速率(半衰期84分钟)。用庚二酸二甲酯使90 kDa热休克蛋白(hsp90)与MR的配体结合亚基共价连接,并未显著改变螺内酯从受体上解离的速率(半衰期96分钟),排除了拮抗剂快速解离速率与hsp90释放有关的可能性。醛固酮和两种抗盐皮质激素对MR的8 - 9S异源寡聚体结构的影响显著不同。使用低盐密度梯度离心分析,醛固酮标记的受体以8 - 9S复合物形式回收,而螺内酯和孕酮结合后检测到4S实体。这表明,在所使用的实验条件下,醛固酮拮抗剂促进hsp90释放,因此不能稳定MR的非DNA结合8 - 9S形式。我们提出,配体的快速解离和hsp90 - 受体相互作用减弱的共同作用参与了醛固酮拮抗剂的抗盐皮质激素活性。